Insulet CORP Form 4 insider transactions

Insulet Corporation's President and CEO, Ashley McEvoy, received annual equity awards consisting of restricted stock units and non-qualified stock options.

An Insulet Corporation director acquired over 2,000 shares of common stock for approximately $500,000, signaling confidence in the company's future.

Insulet Corporation's President and CEO, Ashley McEvoy, acquired 4,300 shares of common stock for approximately $1.03 million, signaling strong insider confidence.

Insulet Corporation's SVP of Regulatory, Quality & Compliance, Laetitia Cousin, disposed of 140 shares of common stock to cover tax obligations related to RSU vesting.

Insulet Corporation Director Robert Luther Huffines acquired 50.8127 shares of common stock through the company's deferred compensation plan.

Insulet Corp. Director Frederick Wayne A.I. sold 1,851 shares of common stock for approximately $542,000 in a pre-scheduled transaction.

Insulet Corporation Director Timothy C. Stonesifer acquired 962 shares of common stock at $311.73 per share under a pre-arranged trading plan.

Insulet Corporation Director Robert Luther Huffines received an initial equity award of 477 restricted stock units, vesting on April 30, 2026.

Insulet's EVP & CFO, Flavia Pease, received 11,708 Restricted Stock Units and 1,641 stock options as equity compensation.

Insulet Corporation's SVP of Global Operations, Prem Singh, sold 687 shares of common stock for a weighted average price of $347.49 per share as part of a pre-arranged trading plan.

Insulet Corporation's SVP of Regulatory, Quality & Compliance, Laetitia Cousin, reported exercising stock options and subsequently selling a portion of her common stock holdings.

Insulet's EVP, CPXO, Eric Benjamin, sold 4,263 shares of common stock for $332.23 per share on August 21, 2025, as part of a pre-arranged trading plan.

Insulet Director Michael R. Minogue reported transfers of common stock, including gifts to a spouse's trust and receipt from a GRAT.

Insulet's SVP of Global Operations, Prem Singh, exercised stock options and subsequently sold a portion of common stock under a pre-arranged trading plan.

Insulet Corporation's SVP, Chief HR Officer Lisa Blair Davis received 2,477 restricted stock units and 1,869 stock options.

Insulet Corporation's Senior Vice President of Global Operations, Prem Singh, engaged in pre-planned transactions, exercising stock options and selling common stock on June 13, 2025, as disclosed in a recent SEC Form 4 filing.

Dan Manea, SVP and Chief HR Officer of Insulet Corp (PODD), sold 1,300 shares of common stock for approximately $390,065 under a Rule 10b5-1 trading plan.

Insulet Corporation Director Luciana Borio reported the sale of 481 shares of common stock for approximately $147,000, executed under a pre-arranged Rule 10b5-1 trading plan.

Insulet Corporation Director Elizabeth H. Weatherman was granted 778 restricted stock units as part of an annual equity award, vesting fully by April 30, 2026.

Insulet Corporation's Director, Frederick Wayne A.I., was granted 778 restricted stock units as part of his annual equity compensation, vesting in April 2026.

Insulet Corporation's Director, Timothy C. Stonesifer, was granted 778 restricted stock units as part of an annual equity award, vesting on April 30, 2026.

Insulet Corporation's Director, Timothy J. Scannell, was granted 778 restricted stock units as part of an annual equity award, increasing his total beneficial ownership to 31,364 shares.

Insulet Corporation's Director, Flavia Pease, was granted 778 restricted stock units as part of her annual equity award, with vesting scheduled for April 30, 2026.

Insulet Corporation Director Michael R. Minogue was granted 778 restricted stock units as part of his annual equity compensation, vesting in full on April 30, 2026.

Insulet Corporation's Director, Jessica Hopfield, was granted 778 restricted stock units as part of an annual equity award, vesting fully by April 30, 2026.

Insulet Corporation's Director, Luciana Borio, has been granted 778 restricted stock units (RSUs) as part of her annual equity compensation, aligning her interests with shareholders.

John W. Kapples, SVP and General Counsel of Insulet Corp, exercised stock options and sold shares on May 14, 2025.

Insuleet Corp's CEO, Ashley McEvoy, reports the acquisition of common stock and stock options, according to a Form 4 filing with the SEC.

Director Jessica Hopfield exercised stock options and sold shares of Insuleet Corp on May 13, 2025.

Executive VP Benjamin Eric of Insulet Corp reports the sale of 3,001 shares of common stock at $320 per share, while also exercising options to acquire 3,001 shares at $92.11.